ha14-1 has been researched along with donepezil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
Miki, A; Morimoto, T; Okada, M; Otori, Y; Tano, Y | 1 |
2 other study(ies) available for ha14-1 and donepezil
Article | Year |
---|---|
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |
Protective effect of donepezil on retinal ganglion cells in vitro and in vivo.
Topics: Administration, Oral; Animals; Axotomy; Benzopyrans; Cell Survival; Cells, Cultured; Cholinergic Antagonists; Cholinesterase Inhibitors; Cytoprotection; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Glutamic Acid; Indans; Mecamylamine; Neuroprotective Agents; Nitriles; Optic Nerve Injuries; Piperidines; Rats; Retinal Ganglion Cells; Scopolamine | 2006 |